Topical Analgesics

Topical Analgesics Market Outlook

The global topical analgesics market is projected to reach approximately USD 12 billion by 2035, growing at a CAGR of around 4.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing prevalence of chronic pain conditions, the rising older population, and the growing demand for non-invasive pain management solutions. Furthermore, the shift in consumer preference towards over-the-counter (OTC) medications rather than prescription drugs is significantly driving the market expansion. Awareness regarding the side effects of oral analgesics is also pushing patients to consider topical alternatives, making topical analgesics a favorable choice. The advancements in formulation technologies are enhancing the effectiveness of these products, contributing to the competitive edge in the market landscape.

Growth Factor of the Market

The topical analgesics market is experiencing significant growth driven by various factors. One of the primary contributors is the increasing incidence of musculoskeletal disorders, which affect a substantial portion of the population globally. Additionally, the rising awareness regarding pain management and the availability of a wide range of topical analgesics in pharmacies and online platforms are boosting market demand. The trend of self-medication has gained momentum, especially among young adults and middle-aged individuals, who are seeking quick relief from pain without the need for a prescription. Moreover, the shift towards natural and herbal pain relief products is fostering innovation in the development of topical analgesics, leading to an increase in product offerings. Technological advancements in drug delivery systems are also enhancing the efficacy and absorption rates of these topical solutions, further propelling market growth.

Key Highlights of the Market

• The market is expected to witness an increase in consumer preference for OTC topical analgesics, driven by convenience and accessibility.
• Technological innovations in formulation and delivery methods are likely to improve product effectiveness and customer satisfaction.
• The growing geriatric population, which is more prone to chronic pain conditions, is anticipated to be a key market driver.
• Rising awareness about the side effects associated with oral analgesics is pushing consumers towards topical alternatives.
• The expansion of e-commerce platforms is enhancing product availability, allowing consumers to purchase topical analgesics with ease.

By Product Type

Creams:

Creams are one of the most popular forms of topical analgesics due to their ease of application and ability to penetrate the skin effectively. These products often contain a combination of analgesic agents and moisturizing ingredients, making them suitable for a variety of pain conditions. The growing demand for pain relief solutions, especially among individuals with localized pain, has led to extensive research and development in this segment. Creams are favored for their non-greasy texture, allowing for comfortable use throughout the day. Moreover, the flexibility in formulation enables manufacturers to offer creams with varying strengths and additional benefits, such as anti-inflammatory properties, further increasing their market appeal.

Patches:

Patches represent a convenient and effective method for delivering analgesics directly to the site of pain. These transdermal patches are designed to provide prolonged relief by slowly releasing medication over time, making them ideal for chronic pain management. Their discreet nature allows users to wear them under clothing without drawing attention. The advancements in patch technology have resulted in improved adhesion and drug release profiles, enhancing user experience and effectiveness. The ability to provide consistent dosing over an extended period has made patches particularly popular among patients who require ongoing pain management. With the increasing focus on convenience and effective pain relief, the patch segment is expected to witness substantial growth in the coming years.

Gels:

Gels are known for their rapid absorption and cooling effect, which can provide immediate relief from pain and inflammation. They are often utilized for conditions such as muscle strains, sports injuries, and topical pain relief. The gel formulations are characterized by their lightweight texture, which allows for easy application and non-greasy feel, making them suitable for active individuals. The effectiveness of gels is attributed to their ability to deliver active ingredients quickly through the skin, leading to faster pain relief. Additionally, the presence of soothing agents in gel formulations enhances the overall experience for users, contributing to their growing popularity in the market.

Sprays:

Sprays are increasingly favored for their ease of use and quick application, allowing users to target specific areas of pain without needing to touch the affected area. This method minimizes the risk of contamination and is particularly beneficial for individuals with limited mobility or those recovering from injuries. The spray format provides a cooling sensation upon application, which can further aid in pain relief. Furthermore, the availability of various formulations catering to different types of pain has led to a rise in consumer interest in spray products. With the growing demand for fast-acting pain relief solutions, sprays are expected to see significant growth in the topical analgesics market.

Roll-Ons:

Roll-ons are a user-friendly solution that combines the benefits of topical analgesics with a massage-like application. The ball applicator allows for targeted delivery of the analgesic to the affected area, enhancing the overall effectiveness of the product. Roll-ons often contain ingredients that provide both immediate cooling and long-lasting pain relief, making them particularly appealing to athletes and active individuals. The compact design of roll-ons makes them convenient for on-the-go use, driving their popularity among consumers. As the demand for multi-functional products that incorporate pain relief and ease of application continues to rise, roll-ons are positioned for growth within the market.

By Application

Muscle Pain:

The muscle pain segment is one of the largest contributors to the demand for topical analgesics, driven by a high prevalence of strains, sprains, and overuse injuries. Athletes and active individuals often seek topical solutions for quick relief from muscle soreness, leading to a growing market for products targeting this application. Topical analgesics provide localized pain relief without the systemic side effects associated with oral medications, making them an attractive option for muscle pain management. The increasing participation in sports and fitness activities continues to fuel the demand for effective muscle pain relief solutions, ensuring that this segment remains robust.

Joint Pain:

Joint pain is a common issue affecting millions globally, particularly among older adults suffering from conditions such as osteoarthritis and rheumatoid arthritis. The use of topical analgesics for joint pain relief has gained popularity as they offer a viable alternative to oral medications, which may have unwanted side effects. These products can provide targeted relief, reducing inflammation and pain directly at the joint site. The growing aging population along with the rising awareness about non-invasive pain management solutions is expected to drive the growth of the joint pain application segment substantially over the coming years.

Back Pain:

Back pain is one of the leading causes of disability worldwide, prompting significant demand for effective topical analgesics that can alleviate discomfort. The use of topical treatments allows individuals to manage their pain without relying solely on prescription medications. Topical analgesics can be easily applied to the lower back, providing localized relief that can enhance mobility and improve quality of life. The increasing sedentary lifestyle and prevalence of back-related ailments, especially among office workers, have heightened the need for accessible pain relief solutions, making this segment a crucial area for growth within the topical analgesics market.

Arthritis:

Arthritis is a chronic condition characterized by inflammation of the joints, leading to significant pain and discomfort. Topical analgesics have emerged as a popular choice for managing arthritis pain due to their localized action and minimal systemic side effects. These products allow patients to apply medication directly to the affected joints, providing targeted relief and improving overall joint function. The increasing patient preference for non-invasive treatments and the growing number of arthritis cases driven by an aging population are key factors contributing to the growth of this segment. The market for arthritis-related topical analgesics is expected to expand as more patients seek effective pain management solutions.

Neuropathic Pain:

Neuropathic pain is a complex condition that often requires specialized treatment options. Topical analgesics designed for neuropathic pain management are gaining traction due to their ability to provide localized relief without the systemic effects of oral medications. These products often contain specific ingredients that target nerve pain, offering patients an alternative or adjunct to traditional pain management therapies. As the understanding of neuropathic pain evolves and the demand for effective treatment options increases, the market for topical analgesics in this application segment is expected to grow significantly, reflecting the need for innovative pain relief solutions.

By Distribution Channel

Pharmacies:

Pharmacies serve as a primary distribution channel for topical analgesics, offering consumers easy access to a wide range of products. These retail outlets are preferred for their professional guidance, where pharmacists can provide recommendations tailored to individual needs. The availability of both prescription and over-the-counter products makes pharmacies a convenient one-stop shop for pain management solutions. Additionally, the growing trend of self-medication has led to an increase in demand for OTC topical analgesics, further contributing to the prominence of pharmacies in this market segment.

Online Retail:

The rise of e-commerce has transformed the distribution landscape for topical analgesics, allowing consumers to conveniently purchase products from the comfort of their homes. Online retail platforms provide a vast selection of topical analgesics, often at competitive prices, appealing to a tech-savvy consumer base. The ability to compare products and read reviews contributes to informed purchasing decisions, while home delivery enhances convenience. As more consumers embrace online shopping, particularly in the wake of the COVID-19 pandemic, this distribution channel is expected to witness significant growth in popularity and market share.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets play a crucial role in the distribution of topical analgesics, offering a wide variety of products in a single location. These large retail formats attract consumers seeking convenience and one-stop shopping experiences, allowing them to purchase topical analgesics alongside other household needs. The presence of well-known brands in supermarkets enhances consumer trust and brand recognition. As shoppers increasingly prefer to buy analgesics during routine grocery trips, the importance of supermarkets and hypermarkets as distribution channels is anticipated to grow.

Health Stores:

Health stores, often specializing in wellness and natural products, have become a significant distribution channel for topical analgesics, particularly those that are herbal or organic. These outlets cater to health-conscious consumers who are seeking alternatives to conventional pain relief options. The increasing demand for natural and holistic remedies has prompted health stores to expand their product offerings, providing a diverse range of topical analgesics that align with consumer preferences. As awareness regarding the benefits of natural ingredients continues to rise, health stores are expected to see sustained growth in the sales of topical analgesics.

Convenience Stores:

Convenience stores are emerging as an important distribution channel for topical analgesics due to their accessibility and extended operating hours. Consumers often turn to convenience stores for quick purchases, especially for over-the-counter pain relief products. The compact nature of these stores allows for easy browsing, making it simple for consumers to find topical analgesics without extensive searching. As the fast-paced lifestyle of consumers continues to drive demand for quick and accessible solutions, the role of convenience stores in the topical analgesics market is likely to expand.

By Ingredient Type

Menthol:

Menthol is one of the most widely used ingredients in topical analgesics due to its cooling and soothing properties. It provides a counterirritant effect, which helps to relieve pain by distracting the brain from deeper pain signals. Menthol-based topical analgesics are particularly popular among athletes and individuals dealing with muscle aches and joint pain, as they offer immediate relief. The ingredient's natural origin and effectiveness have led to its incorporation in a wide variety of pain relief products, supporting its position as a leading ingredient type in the topical analgesics market.

Lidocaine:

Lidocaine is a local anesthetic commonly used in topical analgesics to provide pain relief by blocking nerve signals in the targeted area. It is particularly effective for managing chronic pain conditions, such as arthritis or neuropathic pain. The inclusion of lidocaine in topical formulations allows for a targeted approach to pain management, offering patients an alternative to oral medications. The growing demand for lidocaine-based products, especially in the form of patches and creams, highlights its significance within the topical analgesics market as a preferred ingredient for consumers seeking effective pain relief solutions.

Capsaicin:

Capsaicin, derived from chili peppers, has become an increasingly popular ingredient in topical analgesics for its unique pain-relieving properties. By working to deplete substance P, a pain-signaling molecule, capsaicin can provide lasting relief from various types of pain, including arthritis and neuropathic pain. Many consumers are drawn to capsaicin-based products due to their natural origins and perceived health benefits. The growing trend toward natural and holistic pain management solutions has bolstered the market for capsaicin-containing topical analgesics, making it a significant ingredient type.

Methyl Salicylate:

Methyl salicylate is another key ingredient in topical analgesics, known for its warming sensation and anti-inflammatory properties. It is often combined with other analgesics to enhance the overall effectiveness of the product. Methyl salicylate is particularly favored for muscle pain and joint discomfort, making it a staple in many pain relief creams and gels. The ingredient's dual action of providing both heat and analgesic effects makes it popular among athletes and individuals seeking both immediate and long-term relief from pain. Its effectiveness contributes significantly to its demand within the topical analgesics market.

Camphor:

Camphor is a natural compound used in topical analgesics to relieve pain and reduce inflammation. It produces a cooling effect and serves as a counterirritant, helping to alleviate discomfort in areas such as sore muscles and joint pain. The pleasant aroma of camphor also has a soothing quality, making it a popular choice for various formulations. As consumers increasingly value natural ingredients in pain relief products, camphor's presence in topical analgesics reinforces its relevance in the market. Its combination of effectiveness and natural origin supports its position as a favored ingredient type among consumers.

By Region

Regionally, North America is the dominant market for topical analgesics, accounting for a significant share of the global market. The region's advanced healthcare infrastructure, coupled with high consumer awareness regarding pain management, drives the demand for topical analgesics. The prevalence of chronic pain conditions, particularly among the aging population, contributes to market growth. North America is expected to maintain its leading position, with a CAGR of around 4% projected through 2035, as innovations in product formulations and increasing OTC sales propel the market further. The competitive landscape in North America remains strong, with numerous well-established brands and numerous new entrants capturing consumer interest.

In contrast, the Asia Pacific region is anticipated to witness the highest growth rate in the topical analgesics market, fueled by a rising population, increasing disposable income, and growing awareness of pain management solutions. The expanding healthcare sector in countries like India and China is also expected to enhance the availability of topical analgesics, making them more accessible to consumers. Additionally, the increasing prevalence of arthritis and other chronic pain conditions in the region will bolster demand for effective pain relief products. As consumer preferences shift towards non-invasive solutions, the Asia Pacific market is projected to experience a CAGR of approximately 6% during the forecast period, reflecting the increasing acceptance of topical analgesics across different demographics.

Opportunities

The topical analgesics market presents numerous opportunities for growth, particularly in the realm of product innovation. As consumers become increasingly health-conscious and aware of the side effects associated with oral medications, there is a growing demand for natural and herbal ingredients in topical formulations. Manufacturers can capitalize on this trend by developing new products that incorporate effective natural ingredients, catering to the preferences of health-conscious consumers. Additionally, advancing formulation technologies, such as nanoencapsulation and enhanced drug delivery systems, can provide opportunities for creating more effective and targeted formulations. These innovations can lead to an expansion of product offerings, which can ultimately capture a larger market share.

Another significant opportunity lies in the expansion of distribution channels, particularly in emerging markets. As e-commerce continues to reshape the retail landscape, companies can enhance their online presence to reach a wider audience. Establishing partnerships with e-commerce platforms and optimizing digital marketing strategies can drive sales and enhance brand visibility. Moreover, targeting demographics such as younger consumers and athletes through tailored marketing campaigns can further increase the market penetration of topical analgesics. As the global economy continues to recover from the impacts of the pandemic, the potential for growth in the topical analgesics market is substantial, with numerous opportunities awaiting exploitation.

Threats

While the topical analgesics market is poised for growth, it is not without challenges. The increasing competition from alternative pain management therapies, including prescription medications, physical therapy, and alternative treatments such as acupuncture, poses a significant threat. Many consumers may opt for these alternatives, perceiving them as more effective solutions for chronic pain management. Additionally, the presence of counterfeit products in the market can undermine consumer confidence and negatively impact the overall reputation of topical analgesics. Regulatory challenges, including stringent approval processes and compliance requirements for product formulations, also present hurdles for manufacturers seeking to introduce new products to the market. Thus, maintaining quality and establishing trust are crucial for industry players to thrive.

Furthermore, rising raw material costs and supply chain disruptions can impact the profitability of companies operating in the topical analgesics segment. Fluctuations in the prices of key ingredients, such as menthol or lidocaine, can directly affect production costs, leading to increased prices for end consumers. With consumers becoming more price-sensitive, maintaining competitive pricing while ensuring product quality can be a challenging balancing act. Companies must also remain vigilant about changing consumer preferences and trends, which may shift rapidly, requiring them to adapt their product offerings accordingly. These threats necessitate strategic planning and agility to sustain growth in the topical analgesics market.

Competitor Outlook

• Johnson & Johnson
• Pfizer Inc.
• GlaxoSmithKline PLC
• Bayer AG
• Sanofi S.A.
• Haleon
• Novartis AG
• Reckitt Benckiser Group PLC
• Hisamitsu Pharmaceutical Co., Inc.
• Mentholatum Company, Inc.
• Walgreens Boots Alliance, Inc.
• Procter & Gamble Co.
• Henkel AG & Co. KGaA
• CuraPharm
• Himalaya Drug Company

The competitive landscape of the topical analgesics market is characterized by the presence of several well-established companies alongside emerging players. Major pharmaceutical and consumer goods companies dominate the market, leveraging their strong distribution networks and brand recognition to capture consumer interest. Companies like Johnson & Johnson and Pfizer Inc. offer a wide range of topical analgesics that cater to various pain conditions, ensuring a diverse product portfolio. The focus on research and development is crucial for these companies to innovate and introduce new formulations that meet evolving consumer needs. Additionally, mergers and acquisitions are common strategies employed by larger firms to consolidate their market position and expand their product offerings.

In recent years, companies such as GlaxoSmithKline and Bayer AG have also made strides in the topical analgesics market by enhancing their formulations and improving the bioavailability of their products. This has been achieved by incorporating advanced delivery technologies and focusing on natural ingredients, which resonate well with today's health-conscious consumers. The emphasis on sustainability and ethical sourcing of ingredients has become increasingly important, influencing consumer purchasing decisions. As a result, companies are now prioritizing transparency in their supply chains and product formulations, which is expected to enhance brand loyalty and consumer trust.

Emerging players, such as Haleon, are gaining traction by focusing on niche markets and catering to specific consumer demographics. Their approach often involves leveraging innovative marketing strategies and digital platforms to connect with younger consumers who prioritize convenience and efficacy. Companies like Hisamitsu Pharmaceutical Co., Inc. and Mentholatum Company, Inc. focus on traditional pain relief methods while also exploring new avenues for product development. As the market evolves, collaboration with healthcare professionals and leveraging customer feedback will be essential for companies aiming to differentiate themselves in the competitive landscape of the topical analgesics market.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Haleon
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Bayer AG
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 CuraPharm
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Novartis AG
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Pfizer Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Sanofi S.A.
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Johnson & Johnson
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 GlaxoSmithKline PLC
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Henkel AG & Co. KGaA
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Procter & Gamble Co.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Himalaya Drug Company
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Mentholatum Company, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Reckitt Benckiser Group PLC
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Walgreens Boots Alliance, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Hisamitsu Pharmaceutical Co., Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Topical Analgesics Market, By Application
    • 6.1.1 Muscle Pain
    • 6.1.2 Joint Pain
    • 6.1.3 Back Pain
    • 6.1.4 Arthritis
    • 6.1.5 Neuropathic Pain
  • 6.2 Topical Analgesics Market, By Product Type
    • 6.2.1 Creams
    • 6.2.2 Patches
    • 6.2.3 Gels
    • 6.2.4 Sprays
    • 6.2.5 Roll-Ons
  • 6.3 Topical Analgesics Market, By Ingredient Type
    • 6.3.1 Menthol
    • 6.3.2 Lidocaine
    • 6.3.3 Capsaicin
    • 6.3.4 Methyl Salicylate
    • 6.3.5 Camphor
  • 6.4 Topical Analgesics Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Online Retail
    • 6.4.3 Supermarkets/Hypermarkets
    • 6.4.4 Health Stores
    • 6.4.5 Convenience Stores

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Topical Analgesics Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Topical Analgesics market is categorized based on

By Product Type

• Creams
• Patches
• Gels
• Sprays
• Roll-Ons

By Application

• Muscle Pain
• Joint Pain
• Back Pain
• Arthritis
• Neuropathic Pain

By Distribution Channel

• Pharmacies
• Online Retail
• Supermarkets/Hypermarkets
• Health Stores
• Convenience Stores

By Ingredient Type

• Menthol
• Lidocaine
• Capsaicin
• Methyl Salicylate
• Camphor

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Johnson & Johnson
• Pfizer Inc.
• GlaxoSmithKline PLC
• Bayer AG
• Sanofi S.A.
• Haleon
• Novartis AG
• Reckitt Benckiser Group PLC
• Hisamitsu Pharmaceutical Co., Inc.
• Mentholatum Company, Inc.
• Walgreens Boots Alliance, Inc.
• Procter & Gamble Co.
• Henkel AG & Co. KGaA
• CuraPharm
• Himalaya Drug Company